PIramed, a biotechnology company co-founded by Peter Parker, who was a postdoc with Philip Cohen in the Unit from 1980-1983, has just signed a development deal with Genentech for US$ 275 million. It has been quite a year for Peter who was elected a Fellow of the Royal Society in June 2006.